• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD MYAIRVO 2 HUMIDIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD MYAIRVO 2 HUMIDIFIER Back to Search Results
Model Number PT100
Device Problems Defective Alarm (1014); Output Problem (3005)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
A distributor in australia reported that the audible alarm of a pt100 myairvo 2 humidifier was not functioning.There was no patient involvement.
 
Manufacturer Narrative
(b)(4).The pt100 myairvo 2 humidifier (myairvo 2) device is an active humidifier with integrated flow generator that delivers high flow warmed and humidified respiratory gases to spontaneously breathing patients through a variety of patient interfaces.It's intended use is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.The myairvo device should not be used for life support purposes, and appropriate patient monitoring must be used at all times.The myairvo speaker is intended to provide auditory alerts to the user and auditory alarms under certain conditions.The alarm system functionality must be checked prior to each patient use.The user instructions warn "if either alarm signal is absent, do not use the unit.Contact your fisher & paykel healthcare representative".In the case of speaker failures, a speaker will typically provide a distorted, intermittent or reduced sound level before becoming completely inaudible over time.This contributes to the early detection of this fault by users.It should also be noted that in the event of a speaker failure during use, the myairvo will continue to deliver therapy as per the set parameters.For any alarm condition, the device simultaneously displays a visual alarm alongside auditory alarms and so in the absence of an audible alarm due to speaker failure, a visual alarm will still be displayed.Fisher & paykel healthcare (f&p) has requested for the complaint device to be returned for evaluation.We will provide a follow up report upon completion of our investigation.
 
Manufacturer Narrative
(b)(4).Product background: the pt100 myairvo 2 humidifier (myairvo 2) device is an active humidifier with integrated flow generator that delivers high flow warmed and humidified respiratory gases to spontaneously breathing patients through a variety of patient interfaces.It's intended use is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.The myairvo device should not be used for life support purposes, and appropriate patient monitoring must be used at all times.Method: the complaint myairvo 2 was not returned to fisher & paykel healthcare (f&p) for evaluation.The complaint device is no longer in use.Our investigation is based on the information provided by the customer, previous investigations of similar complaints, and our knowledge of the product.Results: the customer has stated that the myairvo 2 has audio problems.The speaker is a supplied component that is assembled into the myairvo 2.The myairvo 2 speaker is intended to provide auditory alerts to the user and auditory alarms under certain conditions.The alarm system functionality must be checked prior to each patient use.The user instructions warn "if either alarm signal is absent, do not use the unit.Contact your fisher & paykel healthcare representative".In the case of speaker failures, a speaker will typically provide a distorted, intermittent or reduced sound level before becoming completely inaudible over time.This contributes to the early detection of this fault by users.It should also be noted that in the event of a speaker failure during use, the myairvo 2 will continue to deliver therapy as per the set parameters.For any alarm condition, the device simultaneously displays a visual alarm alongside auditory alarms and so in the absence of an audible alarm due to speaker failure, a visual alarm will still be displayed.Conclusion: we are unable to confirm the cause of the failure, however as part of ongoing product improvement initiatives, additional production quality controls at the supplier and at f&p were introduced.This included updated assembly processes, equipment and functional testing to verify speaker performance.A change was made to the instructions for use, to include instructions to verify the functionality of the speaker prior to each patient use.Additionally, a new speaker from a new supplier was also implemented in august 2017.All above actions were implemented and achieved a 98% reduction in the number of complaints for units manufactured after august 2017.Further improvements were initiated in march 2019 which involved an update to the control pcb in order to reduce the mechanical stress on the speaker when operating.The majority of reported speaker failures received currently, continue to be from units manufactured prior to the speaker change implemented in august 2017.The overall number of complaints also continues to decrease as the majority of units manufactured prior to the change are no longer in the field.The current failure rate per use for units manufactured after the change is less than (b)(4) worldwide.
 
Event Description
A distributor in australia reported that a pt100 myairvo 2 humidifier has audio problems.There was no patient involvement as the issue was found whilst the device was not in use on a patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYAIRVO 2 HUMIDIFIER
Type of Device
MYAIRVO 2 HUMIDIFIER
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
faranak gomarooni
17400 laguna canyon road
suite 300
irvine, CA 92618
9494534002
MDR Report Key14504538
MDR Text Key298210231
Report Number9611451-2022-00495
Device Sequence Number1
Product Code BTT
UDI-Device Identifier09420012447319
UDI-Public(01)09420012447319(10)2100634008(11)181113
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K131895
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberPT100
Device Catalogue NumberPT100
Device Lot Number2100634008
Was Device Available for Evaluation? No
Date Manufacturer Received07/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/13/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-